DMAC vs ILMN · $157.4M cap vs rev $4.34B
DiaMedica Therapeutics Inc (DMAC) versus Illumina Inc (ILMN) — a side-by-side from cached financials, not a winner call.
DiaMedica Therapeutics Inc (DMAC) is a biotechnology company listed on US.
Illumina Inc (ILMN) is a diagnostics & research company listed on US.
DMAC does not have a complete income-statement cache yet.
Latest reported ILMN revenue for 2025-12-28 was $4.34B. Net income was $850.0M. Revenue was down 0.7% from 2024-12-29 to 2025-12-28. ILMN currently screens at market cap $15.84B.
DMAC currently screens at market cap $157.4M. ILMN currently screens at market cap $15.84B.
Not investment advice. Open the DMAC and ILMN stock pages for the full models.
Not investment advice.